Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Univo Pharmaceuticals Ltd (UNVO)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
93,000.0 0.0    0.00%
25/04 - Closed. Currency in ILS ( Disclaimer )
Type:  Equity
Market:  Israel
ISIN:  IL0010935588 
S/N:  1093558
  • Volume: 0
  • Bid/Ask: 9.4 / 9.6
  • Day's Range: 93,000.0 - 93,000.0
Univo Pharma 93,000.0 0.0 0.00%

UNVO User Rankings

 
Users ranking according to the performance of their sentiments for the Univo Pharmaceuticals Ltd stock.
RankUsernameTotalClosedWinningWin %Chg. %
1Victoria Shmueli222100+83.07%
2דתדלדח לקל111100+79.83%
3Itay Edelstein111100+78.44%
4Daniel Adler33266.67+69.37%
5Dennis Luks111100+55.86%
6ערן גוט33266.67+50.47%
7Michael Attias111100+48.2%
8Daniel Tordjman33266.67+47.97%
9vladimir girshevich111100+42.32%
10עידן בן עמי111100+40.65%
11Aleksey Danilov222100+32.6%
12Shimon Shababo111100+24.83%
13ben shaked111100+24.46%
14Shalom Daniel111100+20.82%
15משה גרנק111100+20.65%
16Edi Avdalimov111100+15.97%
17אלון ברונשטיין111100+12.71%
18יעקב קרלבוים111100+12.24%
19Ron Ben Simon222100+11.13%
20Hen Grinberg111100+6.98%
21???? ?????????22150+6.97%
22Asaf Yehezkel111100+5.81%
23Ori Vaknin111100+4.18%
24Eliahu Benzaqen111100+3.72%
25vbg99111100+1.36%
26Hen Grinberg1100-0.06%
27דור פיטוסי1100-0.57%
28Tomer Krantz1100-1.48%
29רפי ירושלמ22150-1.74%
30Matan Cohen1100-2.83%
31Ofek Solomon1100-3.87%
32יותון גילילוב1100-5.76%
33Amir Bentura1100-6.06%
34Zeev Goldberg1000-6.65%
35ירון בן גל43133.33-7.06%
36יהודה בן חיים1100-8.67%
37משה דיין1100-8.97%
38Arthur Gaba Krayzman1100-9.44%
39אבי ברבי1100-10%
40ניר סודרי66233.33-10.17%
41amir tuviana22150-10.25%
42Edi Avdalimov1100-10.43%
43נתי גואטה1100-11.57%
44Goli Bitt1100-12.79%
45Eyal Zangi2200-12.93%
46Yonatan Shemian1100-13.36%
47idan abu22150-13.5%
48Lior Benichou1100-15.34%
49Lora Etkovitch1100-16.1%
50Dan Olevskiy1100-17.01%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

UNVO Comments

Write your thoughts about Univo Pharmaceuticals Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email